07:08Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:26Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research
06:27A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
08:20Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
09:34Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:14Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 19, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Fernando Abollo-Jiménez1, Rafael Jiménez, Cesar Cobaleda
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. Unamuno s/n, Salamanca, Spain.
Cancer research often overlooks cell differentiation, focusing instead on uncontrolled proliferation. This review explores how cellular reprogramming and plasticity are key to understanding tumor initiation and cancer biology.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: